$MTNB SEC Filings

Pursuant to Section 242 of the General Corporation Law of the State of Delaware, Matinas BioPharma Holdings, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as f...

On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the “Company”), the stockholders approved the authorization of the Board of Directors (the “Board”), in its sole and absolute discretion an...

Acquired 800,000 Warrants to Purchase Common Stock (Other Transaction) ($516K) · Acquired 265 Series C Convertible Preferred Stock (Other Transaction) ($155) · Received 92,100 shares by exercise ($59.4K) · 3 more

Disposed of 1,406 Series C Convertible Preferred Stock (Other Transaction) ($824) · Disposed of 4,798,636 Warrants to Purchase Common Stock (Other Transaction) ($3.09M)